- Home
- CINGW vs ITIC Comparison
CINGW vs ITIC Comparison
Compare CINGW & ITIC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CINGW
- ITIC
- Stock Information
- Founded
- CINGW N/A
- ITIC 1972
- Country
- CINGW United States
- ITIC United States
- Employees
- CINGW 13
- ITIC N/A
- Industry
- CINGW Biotechnology: Pharmaceutical Preparations
- ITIC Specialty Insurers
- Sector
- CINGW Health Care
- ITIC Finance
- Exchange
- CINGW Nasdaq
- ITIC Nasdaq
- Market Cap
- CINGW N/A
- ITIC 437.8M
- IPO Year
- CINGW 2021
- ITIC N/A
- Fundamental
- Price
- CINGW $0.03
- ITIC $234.99
- Analyst Decision
- CINGW
- ITIC
- Analyst Count
- CINGW 0
- ITIC 0
- Target Price
- CINGW N/A
- ITIC N/A
- AVG Volume (30 Days)
- CINGW N/A
- ITIC 11.2K
- Earning Date
- CINGW N/A
- ITIC 05-08-2025
- Dividend Yield
- CINGW N/A
- ITIC 6.66%
- EPS Growth
- CINGW N/A
- ITIC 18.56
- EPS
- CINGW N/A
- ITIC 15.69
- Revenue
- CINGW N/A
- ITIC $261,183,000.00
- Revenue This Year
- CINGW N/A
- ITIC N/A
- Revenue Next Year
- CINGW N/A
- ITIC N/A
- P/E Ratio
- CINGW N/A
- ITIC $15.27
- Revenue Growth
- CINGW N/A
- ITIC 15.26
- 52 Week Low
- CINGW N/A
- ITIC $146.41
- 52 Week High
- CINGW N/A
- ITIC $290.40
- Technical
- Relative Strength Index (RSI)
- CINGW N/A
- ITIC 51.16
- Support Level
- CINGW N/A
- ITIC $237.00
- Resistance Level
- CINGW N/A
- ITIC $245.45
- Average True Range (ATR)
- CINGW 0.00
- ITIC 5.50
- MACD
- CINGW 0.00
- ITIC 0.94
- Stochastic Oscillator
- CINGW 0.00
- ITIC 52.22
About CINGW Cingulate Inc.
Cingulate Inc is a clinical-stage biopharmaceutical company utilizing its proprietary precision timed-release drug delivery platform to build and advance a pipeline of next-generation pharmaceutical products designed to improve the lives of patients suffering from frequently diagnosed conditions characterized by burdensome daily dosing regimens and suboptimal treatment outcomes. The company focuses on the treatment of Attention Deficit/Hyperactivity Disorder (ADHD) and anxiety, and identifying and evaluating additional therapeutic area to use PTR technology to develop future product candidates.
About ITIC Investors Title Company
Investors Title Co operates in the title insurance and exchange services sectors. The title insurance segment, conducted through ITIC and NITIC, offers title insurance policies for residential, commercial, and industrial properties in around 22 states and the District of Columbia, with a focus on the eastern United States. The title insurance segment issues title insurance policies through approved attorneys from underwriting offices and through independent issuing agents. Title insurance policies insure titles to real estate.n The Title Insurance segment contributes the majority of the company's revenue.